Prime Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 32 Year, 14 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -37.71%
- Ebitda -37.71%
- Net Worth -7.63%
- Total Assets 0.08%
About Prime Laboratories
Prime Laboratories Private Limited (PLPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 January 1993 and has a history of 32 years. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Nakul Kapur, Yudhishthira Kapur, and Seema Kapur serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U00000DL1993PTC051872
-
Company No.
051872
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jan 1993
-
Date of AGM
10 Jun 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Prime Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nakul Kapur
|
Director | 07-Jul-1998 | Current |
|
Yudhishthira Kapur
|
Director | 07-Jul-1998 | Current |
|
Seema Kapur
|
Director | 21-Aug-2017 | Current |
Financial Performance of Prime Laboratories.
Prime Laboratories Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 37.71% decrease in profit. The company's net worth dipped by a decrease of 7.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prime Laboratories?
In 2018, Prime Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Yudhishthra Kapur Exports Private LimitedYudhishthira Kapur is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prime Laboratories?
Prime Laboratories has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prime Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prime Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.